PROGENTOS THERAPEUTICS
Live / Allowed — Third extension granted (statement of use) (as of 10 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 14 Feb 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98404794
- Mark type
- Word mark
- Filed
- 14 Feb 2024
- Published for opposition
- 07 Jan 2025
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations used to treat diseases of the central nervous system, neurological diseases, autoimmune disorders, diseases of the central and peripheral nervous system, and musculoskeletal disorders
- Class 042 — Scientific and technological services: Medical and scientific research and development in the field of diseases of the central nervous system, neurological diseases, autoimmune disorders, diseases of the central and peripheral nervous system, and musculoskeletal disorders
Owner
- Progentos Therapeutics, Inc., Watertown, MA, US
- Progentos Therapeutics, Inc., Watertown, MA, US
Prosecution history
- 11 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Aug 2026 — SOU EXTENSION 3 GRANTED
- 10 Aug 2026 — SOU EXTENSION 3 FILED
- 10 Aug 2026 — SOU TEAS EXTENSION RECEIVED
- 23 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Jan 2026 — SOU EXTENSION 2 GRANTED
- 22 Jan 2026 — SOU EXTENSION 2 FILED
- 22 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 13 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Aug 2025 — SOU EXTENSION 1 GRANTED
- 12 Aug 2025 — SOU EXTENSION 1 FILED
- 12 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Jan 2025 — PUBLISHED FOR OPPOSITION